- Filed
- Mar 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 25, 2025 | 157.07M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $100.12M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $124.58M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $53.72M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $169.09M |
| Current Assets | FY 2024 · Dec 31, 2023 | $317.94M |
| Total Assets | FY 2024 · Dec 31, 2023 | $329.59M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 135.41M sh |
| Capex | FY 2024 · Dec 31, 2022 | $14K |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | −$176.17M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $102.3M |
| Eps Diluted restated | FY 2024 · Dec 31, 2022 | −$1.65 |
| Eps Basic restated | FY 2024 · Dec 31, 2022 | −$1.65 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $95.48M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $125.35M |
| Net Income restated | FY 2024 · Dec 31, 2022 | −$223.81M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | −$218.32M |
| Revenue | FY 2024 · Dec 31, 2022 | $2.79M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $237.15M |